The core component of the DAPC is dystroglycan whose insufficient post-translational glycosylation is responsible for sarcoglycanopathies, a clinically heterogeneous group of congenital muscular dystrophies [28]. The gene discussed is DAG1; the disease is congenital muscular dystrophy due to LMNA mutation.